Gimoti Nasal Spray Now Available for Diabetic Gastroparesis
Gimoti, a dopamine-2 (D2) antagonist, is a nasal spray formulation of metoclopramide.
Gastroenterology
Clinically Meaningful Improvements With Ozanimod in UC Trial
The True North study included patients with moderate to severe ulcerative colitis who had an inadequate response to prior treatment.
Fecal Transplant Safe, Effective for C. Difficile Through 6 Months
90 percent of those undergoing FMT had one-month cure; 4 percent had recurrence within six months
OTC Medicines Containing “Clean” Inactive Ingredients Launched
Genexa has launched 4 over-the-counter (OTC) medicines that contain no artificial ingredients.
Clinical Program for Investigational GERD Drug Discontinued
The bile acid sequestrant was designed to be maintained in the stomach over an extended period of time where it was expected to intercept bile before it reached the esophagus.
Prevalence of Adverse Pregnancy Outcomes Assessed With Biologics for IBD
The study aimed to determine the prevalence of adverse pregnancy outcomes associated with biologic use in women with IBD.
Coffee, Tea, Soda Tied to Higher Risk for Gastroesophageal Reflux
Consuming water, juice, milk not linked to increased risk for gastroesophageal reflux symptoms
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1
In July 2020, the FDA Cardiovascular and Renal Drugs Advisory Committee narrowly voted 8 to 7 in favor of the approval of terlipressin for HRS-1.
Dupilumab Gets Breakthrough Therapy Status for Eosinophilic Esophagitis
The designation was based on results from Part A of a double-blind, placebo-controlled, pivotal phase 3 trial.
FDA Fast Tracks SSAO Inhibitor for Nonalcoholic Steatohepatitis
TERN-201 is a highly-selective semicarbazide-sensitive amino oxidase inhibitor.
